Antagonists of the vanilloid receptor subtype 1 (VR1) and uses thereof
The disclosure relates to spiro-chroman compounds of formula (I), wherein the variables X1, X2, Y, R1a, R1, R2a, R2b, A1, A2, A3, and A4 are as defined in the specification. These compounds have vanilloid receptor subtype I (VR1) inhibiting activity and are suitable for use in treating pain, neuropa...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The disclosure relates to spiro-chroman compounds of formula (I), wherein the variables X1, X2, Y, R1a, R1, R2a, R2b, A1, A2, A3, and A4 are as defined in the specification. These compounds have vanilloid receptor subtype I (VR1) inhibiting activity and are suitable for use in treating pain, neuropathic pain, allodynia, pain associated with inflammation or an inflammatory disease, inflammatory hyperalgesia, bladder overactivity, and urinary incontinence. |
---|